Nigde Omer Halisdemir University
ohu.edu.trLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
83
Active
28
Phase 3
0
Total enrollment
8,336
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| ozonated oil | — | — | — | — | — | 1 |
Next readouts
- 2026-04-30
Top conditions
- Postoperative Pain4
- Healthy Young Adults3
- Multiple Sclerosis3
- Sleep3
- Breastfeeding3
- Pain3
- Cesarean Section2
- Fear of Childbirth2
Frequently asked questions about Nigde Omer Halisdemir University
- How many clinical trials does Nigde Omer Halisdemir University have on ClinicalTrials.gov?
- Nigde Omer Halisdemir University is listed as the lead sponsor on 83 clinical trials in ClinicalTrials.gov, 28 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Nigde Omer Halisdemir University's trials are in Phase 3?
- 0 of Nigde Omer Halisdemir University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Nigde Omer Halisdemir University focus on?
- Nigde Omer Halisdemir University's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Healthy Young Adults, Multiple Sclerosis, Sleep, Breastfeeding.
- When are Nigde Omer Halisdemir University's next clinical trial readouts?
- Nigde Omer Halisdemir University has 1 upcoming primary-completion readout tracked here; the soonest is “Postoperative Ozonated Oil Dressing After Open Inguinal Hernia Repair: A Randomized Pilot Trial”, expected around 2026-04-30.